Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020

References

• Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6):2000094.
   Google Scholar
• Lescure F-X, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020;20(6):697–706.
   PubMed Web of Science ®Google Scholar
• Boëlle P-Y, Souty C, Launay T, et al. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 2020;25(14):2000326.
   PubMedGoogle Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581.
   PubMed Web of Science ®Google Scholar
• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–534.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Hayden FG, Cowling BJ, et al. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet. 2009;374(9696):1209–1211.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19 - studies needed. N Engl J Med. 2020;382(13):1194–1196.
   PubMed Web of Science ®Google Scholar
• Kraemer MUG, Yang C-H, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–497.
   PubMed Web of Science ®Google Scholar
• Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368(6491):638–642.
   PubMed Web of Science ®Google Scholar
• Salje H, Tran Kiem C, Lefrancq N, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208–211.
   PubMed Web of Science ®Google Scholar
• Di Domenico L, Pullano G, Sabbatini CE, et al. Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies. BMC Med. 2020;18(1):240.
   PubMed Web of Science ®Google Scholar
• Flahault A, Blanchon T, Dorléans Y, et al. Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res. 2006;15(5):413–421.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus - Interim guidance 20 March 2020 [Internet]. 2020. Available from: WHO/2019-nCoV/SurveillanceGuidance/2020.6
   Google Scholar
• Mehrotra A, Ray K, Brockmeyer DM, et al. Rapidly converting to “virtual practices”: outpatient care in the era of Covid-19 [Internet]. 2020 [cited 2020 May 12]. Available from: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0091
   Google Scholar
• Souty C, Masse S, Valette M, et al. Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care. Clin Microbiol Infect. 2019;25(9):1147–1153.
   PubMed Web of Science ®Google Scholar
• Souty C, Amoros P, Falchi A, et al. Influenza epidemics observed in primary care from 1984 to 2017 in France: a decrease in epidemic size over time. Influenza Other Respir Viruses. 2019;13(2):148–157.
   PubMed Web of Science ®Google Scholar
• Carrat F, Valleron AJ. Epidemiologic mapping using the “kriging” method: application to an influenza-like illness epidemic in France. Am J Epidemiol. 1992;135(11):1293–1300.
   PubMed Web of Science ®Google Scholar
• Flaxman S, Mishra S, Gandy A. et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–261.
   PubMed Web of Science ®Google Scholar
• Dehning J, Zierenberg J, Spitzner FP, et al. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions. Science. 2020;369(6500):eabb9789.
   PubMed Web of Science ®Google Scholar
• Okell LC, Verity R, Watson OJ, et al. Have deaths from COVID-19 in Europe plateaued due to herd immunity? The Lancet. 2020;395(10241):e110–1–e111.
   Web of Science ®Google Scholar
• Cereda D, Tirani M, Rovida F, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. arXiv. 2020.
   PubMedGoogle Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.
   PubMed Web of Science ®Google Scholar
• Cauchemez S, Kiem CT, Paireau J, et al. Lockdown impact on COVID-19 epidemics in regions across metropolitan France. The Lancet. 2020;396(10257):1068–1069.
   PubMed Web of Science ®Google Scholar
• Kuitunen I, Artama M, Mäkelä L, et al. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J. 2020;39(12):e423–e427.
   PubMed Web of Science ®Google Scholar
• Yeoh DK, Foley DA, Minney-Smith CA, et al. The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa1475
   PubMedGoogle Scholar
• Vu SL, Jones G, Anna F, et al. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. medRxiv. 2020. DOI:10.1101/2020.10.20.20213116
   PubMedGoogle Scholar
• Pullano G, Di Domenico L, Sabbatini CE, et al. Underdetection of COVID-19 cases in France threatens epidemic control. Nature. 2020. DOI:10.1038/s41586-020-03095-6
   PubMed Web of Science ®Google Scholar